ADVERTISE HERE 

Building Biotechnology: Starting, managing, and understanding 
biotechnology companies

Pharmaceutical Innovation Dashboard

Drug Patent Expirations in November 2008
*Drugs may be covered by multiple patents
TradenameApplicantGeneric NamePatent NumberPatent Expiration
ALKERANGlaxosmithklinemelphalan hydrochloride4,997,651Nov 18, 2008
BREVIBLOCBaxter Hlthcare Corpesmolol hydrochloride5,017,609Nov 21, 2008
BUSPARBristol Myers Squibbbuspirone hydrochloride5,015,646Nov 14, 2008
COVERA-HSGd Searle Llcverapamil hydrochloride5,030,456Nov 7, 2008
DYNACIRC CRSmithkline Beechamisradipine5,030,456Nov 7, 2008
NEUROLITELantheus Medcltechnetium tc-99m bicisate kit5,279,811Nov 23, 2008
NEURONTINParke Davisgabapentin4,894,476Nov 2, 2008
NEURONTINPfizer Pharmsgabapentin4,894,476Nov 2, 2008
NUVIGILCephalonarmodafinil4,927,855Nov 22, 2008
PRELAYSankyotroglitazone4,572,912Nov 9, 2008
REZULINPfizer Pharmstroglitazone4,572,912Nov 9, 2008

Instant Access with secure payment processing:

Drug
patentsDrug
patent expirationsPatent
expirationDrug sales
$235 / One Month $975 / One Year
One Month One Year
Need an invoice? Group rate? Contact admin@DrugPatentWatch.com
Drug patent expirations by month

Drug patent expirations by year

Number of drug patents per pharmaceutical drug
Number of drugs per drug company

Most patents listed last year

Number of drug patents by drug company
Number of pharmaceutical patent expirations faced by drug companies

Number of approved drugs produced per company

Top selling drugs

Your source for pharmaceutical industry intelligence
Database 
Preview

Subscribe for free drug patent expiration updates

Enter your email address: Also available in a RSS feed Drug Patent
Expiration Newsletter
[ Home | Free Patent Expiration Bulletin | Media Access | Affiliate Program | Contact ]

Bookmark This Site

Drug Patent Expiration Dates